This study is performed to investigate the long-term safety, in particular the diabetogenic
potential and immunogenicity of rhGH therapy in short children born small for gestational
age (SGA).
Minimum age: 4 Years.
Maximum age: 18 Years.
Gender(s): Both.
Sandoz Investigative Site, Edegem, Belgium
Sandoz Investigative Site, Hradec Králové, Czech Republic
Sandoz Investigative Site, Prague, Czech Republic
Sandoz Investigational Site, Ústà nad Labem, Czech Republic
Sandoz Investigative Site, Tiblisi, Georgia
Sandoz Investigative Site, Munich, Germany
Sandoz Investigative Site, Sankt Augustin, Germany
Sandoz Investigative Site, Budapest, Hungary
Sandoz Investigative Site, Győr, Hungary
Sandoz Investigative Site, Miskolc, Hungary
Sandoz Investigative Site, Szeged, Hungary
Sandoz Investigative Site, Bydgoszcz, Poland
Sandoz Investigative Site, Gdańsk, Poland
Sandoz Investigative Site, Katowice, Poland
Sandoz Investigative Site, Kielce, Poland
Sandoz Investigative Site, Kraków, Poland
Sandoz Investigative Site, Lódz, Poland
Sandoz Investigative Site, Poznań, Poland
Sandoz Investigative Site, Rzeszów, Poland
Sandoz Investigative Site, Szczencin, Poland
Sandoz Investigative Site, Warszawa, Poland
Sandoz Investigative Site, Wroclaw, Poland
Sandoz Investigative Site, Wrocław, Poland
Sandoz Investigative Site, Zabrze, Poland
Sandoz Investigative Site, Bucharest, Romania
Sandoz Investigative Site, Cluj Napoca, Romania
Sandoz Investigative Site, Craiova, Romania
Sandoz Investigative Site, Iasi, Romania
Sandoz Investigative Site, Timisoara, Romania